1. Pharmacological Parameters and Pharmacokinetic Variability Derived from Bioequivalence Trials in a Mexican Population..Clin Pharmacol Drug Dev. 2024 Jan;13(1):6-13. doi: 10.1002/cpdd.1343. IMPACT FACTOR: 2.2

2. Pharmacogenetic Variants Associated with Fluoxetine Pharmacokinetics from a Bioequivalence Study in Healthy Subjects. J Pers Med. 2023 Sep 1;13(9):1352. doi: 10.3390/jpm13091352.PMID: 37763120 IMPACT FACTOR: 4.9

3. Unraveling the Role of EV-Derived miR-150-5p in Prostate Cancer. Cancers (Basel). 2023 Aug 17;15(16):4148. doi: 10.3390/cancers15164148. IMPACT FACTOR: 5.2

4. Genetic Determinants of Atherogenic Indexes.Genes (Basel). 2023 Jun 1;14(6):1214. doi: 10.3390/genes14061214.PMID: IMPACT FACTOR: 3.4

5. Transcriptome-Wide Analysis of Low-Concentration Exposure to Bisphenol A, S, and F in Prostate Cancer Cells. Int J Mol Sci. 2023 May 30;24(11):9462. doi: 10.3390/ijms24119462.PMID: 37298413 IMPACT FACTOR: 5.6

6. SFRP1 induces a stem cell phenotype in prostate cancer cells.Front Cell Dev Biol. 2023 Mar 9;11:1096923. doi: 10.3389/fcell.2023.1096923. eCollection 2023.PMID: 36968194 IMPACT FACTOR: 6.08

7. Rapid Identification of Drug Resistance and Phylogeny in M. tuberculosis, Directly from Sputum Samples. Microbiol Spectr. 2022 Oct 26;10(5):e0125222. doi: 10.1128/spectrum.01252-22. PMID: 36102651 IMPACT FACTOR: 9.03

8. Aptamers as Theragnostic Tools in Prostate Cancer..Biomolecules. 2022 Jul 29;12(8):1056. doi: 10.3390/biom12081056.PMID: 36008950 IMPACT FACTOR: 6.1

9. The Potential of Metabolomics in Biomedical Applications.Metabolites. 2022 Feb 19;12(2):194. doi: 10.3390/metabo12020194.PMID: 35208267 IMPACT FACTOR: 4.5

10. Hormone-Related Cancer and Autoimmune Diseases: A Complex Interplay to be Discovered. Front Genet. 2022 Jan 17;12:673180. doi: 10.3389/fgene.2021.673180. eCollection 2021.PMID: 35111194 IMPACT FACTOR: 3.7

11. A bioinformatics pipeline for Mycobacterium tuberculosis sequencing that cleans contaminant reads from sputum samples..PLoS One. 2021 Oct 26;16(10):e0258774. doi: 10.1371/journal.pone.0258774. IMPACT FACTOR: 3.7

12. Transporters, TBC1D4, and ARID5B Variants to Explain Glycated Hemoglobin Variability in Patients with Type 2 Diabetes.Pharmacology. 2021;106(11-12):588-596. doi: 10.1159/000517462. Epub 2021 Jul 15.PMID: 34265779. IMPACT FACTOR: 3.1

13. Genotyping NUDT15*3 rs1166855232 reveals higher frequency of potential adverse effects of thiopurines in Natives and Mestizos from Mexico. Pharmacol Rep. 2022 Feb;74(1):257-262. doi: 10.1007/s43440-021-00287-3. Epub 2021 Jun 6.PMID: 34091879. IMPACT FACTOR: 4.4

14. Association of FAAH p.Pro129Thr and COMT p.Ala72Ser with schizophrenia and comorbid substance use through next-generation sequencing: an exploratory analysis. Braz J Psychiatry. 2022 Mar-Abr;44(2):164-170. doi: 10.1590/1516-4446-2020-1546.PMID: 34037083 IMPACT FACTOR: 6.3

15. New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil. Front Oncol. 2021 Feb 26;11:627229. doi: 10.3389/fonc.2021.627229. eCollection 2021.PMID: 33718200 IMPACT FACTOR: 4.7

16. Allele Frequency of ACE2 Intron Variants and Its Association with Blood Pressure.DNA Cell Biol. 2020 Nov;39(11):2095-2101. doi: 10.1089/dna.2020.5804. Epub 2020 Oct 5.PMID: 33016778. IMPACT FACTOR: 3.1

17. Cell-Internalization SELEX of RNA Aptamers as a Starting Point for Prostate Cancer Research. Methods Mol Biol. 2021;2174:245-254. doi: 10.1007/978-1-0716-0759-6_15.PMID: 32813254. IMPACT FACTOR: 1.2

18. Interaction of FTO rs9939609 and the native American-origin ABCA1 p.Arg230Cys with circulating leptin levels in Mexican adolescents diagnosed with eating disorders: Preliminary results.Psychiatry Res. 2020 Sep;291:113270. IMPACT FACTOR: 11.2 doi: 10.1016/j.psychres.2020.113270. Epub 2020 Jul 2.PMID: 32763537

19. SFRP1 increases TMPRSS2-ERG expression promoting neoplastic features in prostate cancer in vitro and in vivo. Cancer Cell Int. 2020 Jul 16;20:312. doi: 10.1186/s12935-020-01333-5. eCollection 2020.PMID: 32694934 IMPACT FACTOR: 6.4

20. Pharmacogenomics: Current Actionable Variants. Rev Invest Clin. 2020 May 7;73(3). Online ahead of print. PMID: 32488227. IMPACT FACTOR: 2.7

21. Characterization of Polymorphisms Associated with Multidrug-Resistant Tuberculosis by Whole Genomic Sequencing: A Preliminary Report from Mexico.Microb Drug Resist. 2020 Jul;26(7):732-740. doi: 10.1089/mdr.2019.0054. Epub 2019 Dec 23.PMID: 31874045. IMPACT FACTOR: 2.6

22. Genomic diversity of prevalent Staphylococcus epidermidis multidrug-resistant strains isolated from a Children's Hospital in México City in an eight-years survey. PeerJ. 2019 Nov 20;7:e8068. doi: 10.7717/peerj.8068. eCollection 2019.PMID: 31768302 IMPACT FACTOR:3.06

23. Variation in Actionable Pharmacogenetic Markers in Natives and Mestizos From Mexico. Front Pharmacol. 2019 Oct 10;10:1169. doi: 10.3389/fphar.2019.01169. eCollection 2019.PMID: 31649539 IMPACT FACTOR: 5.99

24. Exploratory analysis of rare and novel variants in mexican patients diagnosed with schizophrenia and dementia.Rev Invest Clin. 2019;71(4):246-254. PMID: 31448785 doi: 10.24875/RIC.19002923. IMPACT FACTOR:2.7

25. Anthocyanins of Blue Corn and Tortilla Arrest Cell Cycle and Induce Apoptosis on Breast and Prostate Cancer Cells.Nutr Cancer. 2020;72(5):768-777. doi: 10.1080/01635581.2019.1654529. Epub 2019 Aug 26.PMID: 31448633. IMPACT FACTOR:2.5

26. Whole genomic sequencing as a tool for diagnosis of drug and multidrug-resistance tuberculosis in an endemic region in Mexico. PLoS One. 2019 Jun 5;14(6):e0213046. doi: 10.1371/journal.pone.0213046. eCollection 2019.PMID: 31166945 IMPACT FACTOR 3.7

Circuito de Posgrado, Ciudad Universitaria
Alcaldía Coyoacán, C.P. 04510, México, CDMX

55 5623 7006
mdcbq@posgrado.unam.mx